Brief: Theranexus Announces Issuance Of Chinese Patent Covering Its Drug Candidate THN102

Thx Pharma SA

24/04/2019 06:41

April 24 (Reuters) - THERANEXUS SA  ALTHX.PA :
    * ANNOUNCES ISSUANCE OF CHINESE PATENT COVERING ITS DRUG
CANDIDATE
THN102
    * THIS PATENT WAS GRANTED TO FRENCH ALTERNATIVE ENERGIES AND
ATOMIC ENERGY COMMISSION (CEA) BY CHINESE STATE INTELLECTUAL
PROPERTY OFFICE (SIPO)
    * PATENT ISSUANCE FEE WAS PAID ON 27 MARCH 2019
    * THERANEXUS HOLDS EXCLUSIVE RIGHTS TO PATENT
    * PATENT PROTECTS DRUG CANDIDATE THN102, UNTIL 2034
    * THIS NEW PATENT ISSUANCE WILL BOOST INDUSTRIAL
OPPORTUNITIES FOR
THN102
    * RESULTS OF TRIAL ARE EXPECTED IN SECOND HALF OF 2019

Source text for Eikon:  ID:nACT58028 
Further company coverage:  ALTHX.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))